The first-quarter 2025 earnings season is underway for the Medical sector (one of the 16 broad Zacks sectors within the Zacks Industry classification), with several MedTech companies already releasing their quarterly results. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)Per the latest Earnings Preview, the Medical sector is one of the nine sectors whose first-quarter earnings are expected to be above the year-earlier period. It is also one of the sectors that is likely to witness ...

New whitepaper highlights how a relationship with a Primary Care Physician (“PCP”) that uses Counterpart Assistant is associated with better clinical management, and fewer hospitalizations (18% lower) and readmissions (25% lower) in heart failure patientsWILMINGTON, Del., May 01, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) and a leading AI-powered physician-enablem ...

Core Viewpoint - Clover Health Investments, Corp. announces that Lee A. Shapiro will not seek reelection to the Board of Directors due to new responsibilities as Chairman of the American Heart Association, with his term ending on June 10, 2025 [1][2]. Company Leadership Changes - Lee A. Shapiro has served on Clover Health's Board for four years and has contributed significantly to the company's mission [2]. - Andrew Toy, CEO of Clover Health, expresses gratitude for Shapiro's leadership and insights during his tenure [2]. - Vivek Garipalli, Executive Chairperson and founder, acknowledges Shapiro's unique contributions and announces that Thomas L. Tran will take over as Chairman of the Audit Committee and Nominating and Corporate Governance Committee effective June 10, 2025 [2][3]. Company Overview - Clover Health is a physician enablement technology company focused on providing access to quality healthcare for Medicare recipients, particularly seniors [4]. - The company utilizes its software platform, Clover Assistant, to aggregate patient data and improve health outcomes through early identification and management of chronic diseases [4]. - Clover Health offers PPO and HMO Medicare Advantage plans and extends its technology benefits to a broader audience through its subsidiary, Counterpart Health [4].

WILMINGTON, Del., April 08, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will report first quarter 2025 financial results after market close on Tuesday, May 6, 2025. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on May 6, 2025, to discuss Clover Health’s first quarter 2025 business and financial results. First Quarter 2025 Conference Call and Webcast Details: What: Clover Health’s ...

Core Insights - Clover Health has appointed Dr. Shelly Gupta as Chief Medical Officer, bringing over a decade of Medicare Advantage and healthcare leadership experience [1][2] - Dr. Gupta's role will focus on enhancing clinical operations, quality initiatives, and chronic disease management programs, emphasizing patient choice and provider autonomy [1][3] Company Overview - Clover Health is a physician enablement technology company dedicated to improving access to quality healthcare for Medicare beneficiaries, particularly seniors [5] - The company utilizes its software platform, Clover Assistant, to aggregate patient data and support clinical decision-making, aiming to improve health outcomes and manage chronic diseases [5] Leadership and Strategy - Dr. Gupta has a proven track record in enhancing clinical outcomes for senior populations, having previously held leadership roles at Humana [2][4] - His expertise in operationalizing clinical innovation aligns with Clover Health's mission to simplify healthcare decisions and empower providers [4] Technology and Innovation - Clover Health's strategy includes leveraging advanced data-driven solutions and innovative technology to optimize Medicare Advantage clinical operations [3][4] - The company aims to enhance care delivery and member satisfaction while advancing value-based care initiatives [3]

Group 1 - The article emphasizes the identification of investment opportunities in undervalued companies, leveraging the author's experience in financial markets and institutions [1] - The analysis includes thorough research on financial statements, market trends, and upcoming events that may impact specific companies or industries [1]

Core Viewpoint - Hims & Hers Health Inc. experienced significant stock volatility, reaching an all-time high of nearly $73 before dropping to $36, but there are reasons for investors to remain optimistic about the stock's long-term potential [1][2]. Group 1: Stock Performance - Hims & Hers stock rebounded by 24% from its recent lows, suggesting that the market may have found a bottom [3]. - Clover Health Investments Inc. is currently favored in the market, trading at 82% of its 52-week high, compared to Hims & Hers at only 62% [6]. - Clover's stock price is projected to reach a fair valuation of $5.0 per share, indicating a potential upside of 26% from current levels [10]. Group 2: Financial Metrics - Clover Health reported a 30% annual growth in average Medicare Advantage memberships, contributing to $330.7 million in insurance revenue, a 9.1% increase year-over-year [8]. - Wall Street forecasts earnings per share (EPS) for Clover to improve significantly, with expectations of reaching $0.03 by Q2 2025, up from a current net loss of $0.02 per share [6][7]. Group 3: Investment Sentiment - The Vanguard Group increased its holdings in Clover stock by 2.0%, bringing their total position to $61.7 million, representing 3.9% ownership [12]. - Clover stock is currently trading at a price-to-book (P/B) ratio of 6.6x, which is above the industry average of 4.9x, indicating a premium valuation that some investors are willing to pay for perceived growth potential [12][13].

WILMINGTON, Del., March 03, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. ("Counterpart"), a leading AI-powered physician enablement platform, today announced it has partnered with Google Cloud to integrate Vertex AI Search into its flagship technology, Counterpart Assistant. This innovation gives providers on Counterpart Assistant a generative AI (gen AI) search experience across the breadth of a patient's digital health record to provide contextualized insights, and to make it easier to deliver value- ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ________________________________________ FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission File Number: 001-39252 ________________________________________ Clover Health Investments, C ...

Clover Health Investments, Corp. (CLOV) delivered a fourth-quarter 2024 loss per share of 4 cents, narrower than the year-ago period’s loss of 14 cents. The bottom line beat the Zacks Consensus Estimate of a loss of 7 cents.Adjusted earnings per share from continuing operations were approximately 2 cents against a loss of 5 cents in the year-ago period.CLOV’s Revenues in DetailClover Health registered revenues of $337 million, up 7.9% year over year. However, the figure missed the Zacks Consensus Estimate b ...